Vobramitamab (AEX-4089) is a humanized monoclonal antibody (mAb) targeting the B7-H3 antigen (CD276) which is conjugated to the prodrug seco-duocarmycin hydroxybenzamide azaindole (seco-DUBA) through a enzymatically cleavable peptide-based linker, thereby creating the investigational antibody-drug conjugate (ADC) known as MGC018.
Purity:
95.00%
CAS Number:
[2490556-50-6]
Target:
ADC Antibody
* VAT and and shipping costs not included. Errors and price changes excepted